SOCIETAL IS A SMALL BUSINESS CONCERN FOR DOSAGE FORM DEVELOPMENT, MANUFACTURE, AND STABILITY STUDIES OF NCGC72
$182,902N01FY2023DANIH
Irisys, Inc., San Diego CA
Investigators
Abstract
The scope of this contract is for formulation development of a solid oral dosage form as tablets, validation of analytical methods on drug products, manufacture of pilot batches, GMP drug product for a phase I clinical trial, and long term stability study under ICH guideline.
View original record on NIH RePORTER →